Thonburi Healthcare Group Future Growth
Future criteria checks 4/6
Thonburi Healthcare Group is forecast to grow earnings and revenue by 111% and 13.2% per annum respectively. EPS is expected to grow by 110.8% per annum. Return on equity is forecast to be 6.4% in 3 years.
Key information
111.0%
Earnings growth rate
110.8%
EPS growth rate
Healthcare earnings growth | 10.4% |
Revenue growth rate | 13.2% |
Future return on equity | 6.4% |
Analyst coverage | Low |
Last updated | 14 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 12,421 | 725 | 192 | 2,118 | 3 |
12/31/2025 | 11,452 | 562 | -267 | 1,920 | 3 |
12/31/2024 | 9,741 | 143 | -403 | 1,127 | 1 |
9/30/2024 | 9,279 | -657 | -301 | 1,067 | N/A |
6/30/2024 | 9,491 | 5 | -355 | 1,103 | N/A |
3/31/2024 | 9,672 | 91 | -196 | 1,224 | N/A |
12/31/2023 | 9,844 | 295 | 149 | 1,542 | N/A |
9/30/2023 | 10,214 | 888 | 634 | 2,032 | N/A |
6/30/2023 | 10,430 | 1,016 | 775 | 2,114 | N/A |
3/31/2023 | 10,575 | 1,286 | 926 | 2,241 | N/A |
12/31/2022 | 11,582 | 1,602 | 1,226 | 2,495 | N/A |
9/30/2022 | 12,672 | 1,999 | 1,475 | 2,710 | N/A |
6/30/2022 | 13,579 | 2,393 | 1,741 | 2,595 | N/A |
3/31/2022 | 12,811 | 2,079 | 1,422 | 2,266 | N/A |
12/31/2021 | 10,847 | 1,337 | 1,305 | 2,034 | N/A |
9/30/2021 | 9,215 | 733 | 418 | 1,209 | N/A |
6/30/2021 | 7,267 | -25 | -10 | 1,070 | N/A |
3/31/2021 | 6,941 | -235 | -34 | 1,057 | N/A |
12/31/2020 | 7,315 | 62 | -1,144 | 441 | N/A |
9/30/2020 | 7,549 | 114 | -1,325 | 260 | N/A |
6/30/2020 | 7,872 | 187 | -1,788 | -27 | N/A |
3/31/2020 | 8,300 | 537 | -2,004 | -151 | N/A |
12/31/2019 | 8,232 | 462 | -2,408 | -171 | N/A |
9/30/2019 | 7,999 | 401 | -2,424 | -248 | N/A |
6/30/2019 | 7,617 | 350 | -2,609 | -443 | N/A |
3/31/2019 | 7,283 | 198 | -2,554 | -351 | N/A |
12/31/2018 | 7,094 | 348 | -1,496 | -177 | N/A |
9/30/2018 | 6,949 | 484 | -999 | 103 | N/A |
6/30/2018 | 6,839 | 559 | N/A | 545 | N/A |
3/31/2018 | 6,742 | 617 | N/A | 667 | N/A |
12/31/2017 | 6,612 | 554 | N/A | 713 | N/A |
9/30/2017 | 6,442 | 502 | N/A | 678 | N/A |
12/31/2016 | 6,229 | 511 | N/A | 829 | N/A |
12/31/2015 | 5,787 | 552 | N/A | 588 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: THG-R is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: THG-R is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: THG-R is expected to become profitable in the next 3 years.
Revenue vs Market: THG-R's revenue (13.2% per year) is forecast to grow faster than the TH market (6.8% per year).
High Growth Revenue: THG-R's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: THG-R's Return on Equity is forecast to be low in 3 years time (6.4%).